Sara Altayeb: ESC 2026 Clinical Pearls for Bleeding on Anticoagulation
Sara Altayeb, Internal Medicine Specialist at Virtual Sudan Clinic, shared on LinkedIn:
”Bleeding on Anticoagulation | ESC 2026 Clinical Pearls:
Managing bleeding isn’t just about stopping drugs, it’s about risk stratification plus targeted reversal plus safe restart.
1. Classify First (ESC Approach):
- Minor / self-limited
- Clinically relevant non-major (CRNM)
- Major / Life-threatening
Severity drives everything!
2. What Defines Major Bleeding?
- Hemodynamic instability
- Hb drop ≥ 2 g/dL or transfusion ≥ 2 units
- Critical site (intracranial, GI, retroperitoneal)
Treat immediately!!
3. Know Your Anticoagulant!
- Warfarin (VKA) – check INR
- DOACs – consider last dose + renal function
- Heparin – short half-life (rapid offset)
Drug plus timing equals management strategy!
4. Management by Severity:
Minor:
- Continue anticoagulant
- Local measures only
CRNM:
- Temporarily hold drug
- Treat source
- Review dose and interactions
Major Bleeding:
- Stop anticoagulant
- ABC resuscitation first
- Use reversal
ESC Reversal Pearls:
- Warfarin – PCC + Vitamin K
- Dabigatran – Idarucizumab
- Apixaban/Rivaroxaban – Andexanet alfa (if available) or PCC
- Heparin – Protamine
5. Restarting Anticoagulation:
Restart early once hemostasis achieved
- High thrombotic risk – restart sooner
- Intracranial bleed – delay and individualize
‘Don’t forget why the patient was anticoagulated.’
Take-Home: Classify – Stabilize – Reverse (if needed) – Restart safely.”
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE